Shangqian Wang
Jiangsu Province Hospital(CN)Nanjing Medical University(CN)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Gastrointestinal Tumor Research and Treatment, Sarcoma Diagnosis and Treatment, Renal cell carcinoma treatment, Ubiquitin and proteasome pathways
Most-Cited Works
- → Lineage plasticity in prostate cancer depends on JAK/STAT inflammatory signaling(2022)331 cited
- → Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT–mTORC1 activation(2017)299 cited
- → Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets(2022)256 cited
- → The need for urogenital tract monitoring in COVID-19(2020)105 cited
- → The novel BET‐CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild‐type prostate cancer(2019)87 cited
- → TRIM36, a novel androgen-responsive gene, enhances anti-androgen efficacy against prostate cancer by inhibiting MAPK/ERK signaling pathways(2018)64 cited
- → Relationship Between Marijuana Use and Overactive Bladder (OAB): A Cross-Sectional Research of NHANES 2005 to 2018(2022)56 cited
- → Male reproductive toxicity of perfluorooctanoate (PFOA): Rodent studies(2020)56 cited
- → Dual inhibition of AKT ‐m TOR and AR signaling by targeting HDAC 3 in PTEN ‐ or SPOP ‐mutated prostate cancer(2018)51 cited
- → <p>Multiple Expression Assessments of ACE2 and TMPRSS2 SARS-CoV-2 Entry Molecules in the Urinary Tract and Their Associations with Clinical Manifestations of COVID-19</p>(2020)44 cited